Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.6036 USD
Market Closed
Updated:
May 17, 2024
Atara Biotherapeutics Inc
Common Shares Outstanding
|
Atara Biotherapeutics Inc
Common Shares Outstanding Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Common Shares Outstanding
$120.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$257.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Atara Biotherapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
120.3m
USD
120.3m
USD
Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Common Shares Outstanding amounts to 120.3m USD.
What is Atara Biotherapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
21%
21%
Over the last year, the Common Shares Outstanding growth was 25%. The average annual Common Shares Outstanding growth rates for Atara Biotherapeutics Inc have been 13% over the past three years , 21% over the past five years .
You don't have any saved screeners yet
